Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)

Recruiting

Phase 1

Phase 2

Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)

Sponsor:

Taysha Gene Therapies, Inc.

Code:

NCT06152237

Conditions

Rett Syndrome

Eligibility Criteria

Sex: Female

Age: 5 - 8

Healthy Volunteers: Not accepted

Interventions

TSHA-102

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-15. This information was provided to ClinicalTrials.gov by Taysha Gene Therapies, Inc. on 2025-05-11.